USS Investment Management Ltd increased its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 345.7% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,074 shares of the biotechnology company’s stock after acquiring an additional 48,147 shares during the period. USS Investment Management Ltd’s holdings in Axon Enterprise were worth $26,355,000 as of its most recent SEC filing.
Other hedge funds have also recently bought and sold shares of the company. Darwin Wealth Management LLC acquired a new stake in Axon Enterprise in the second quarter valued at $37,000. Creative Financial Designs Inc. ADV acquired a new position in shares of Axon Enterprise during the 4th quarter worth $28,000. Sound Income Strategies LLC raised its stake in shares of Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after buying an additional 44 shares during the last quarter. Camelot Portfolios LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter worth about $30,000. Finally, AlphaCentric Advisors LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter worth about $34,000. 79.08% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Axon Enterprise
In other news, insider Elizabeth Reid Coughlin sold 1,554 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total value of $753,690.00. Following the completion of the transaction, the insider owned 34,024 shares of the company’s stock, valued at $16,501,640. The trade was a 4.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, June 29th. The shares were sold at an average price of $500.00, for a total transaction of $5,000,000.00. Following the transaction, the chief executive officer directly owned 3,050,997 shares in the company, valued at $1,525,498,500. The trade was a 0.33% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 48,989 shares of company stock valued at $24,090,083. Corporate insiders own 4.20% of the company’s stock.
Axon Enterprise News Summary
- Positive Sentiment: News that President Trump bought Axon shares and that ICE later sought a large Taser contract has fueled speculation about future government demand for Axon’s products. Trump bought as much as $5 million in Axon stock before ICE sought $220 million Taser deal
- Positive Sentiment: Axon’s recent operating momentum is also supporting the stock, including first-quarter revenue growth of 34% year over year and management’s raised 2026 growth outlook. Axon Enterprise jumps as investors react to disclosure-linked contract narrative and strong operating momentum
- Neutral Sentiment: Analysts remain generally constructive, with Northland Securities reiterating a buy rating and several recent price targets clustering well above prior trading levels. Northland Securities Reaffirms Their Buy Rating on Axon Enterprise (AXON)
- Neutral Sentiment: One headline also noted ongoing debate about valuation and whether the stock’s recent rebound is being driven more by momentum and political headlines than fundamentals. Axon Enterprise (AXON) Stock After Recent Volatility Is The Current Price Justified
- Negative Sentiment: The Trump-Axon-ICE connection has also raised ethics and conflict-of-interest questions, which could create political and reputational risk around government contracting. Axon Enterprise (AXON) Stock Drew Ethics Questions After Trump Bought $5 Million In Shares
- Negative Sentiment: Insider selling remains a headwind for sentiment, with the CEO recently selling shares under a pre-arranged trading plan and no insider purchases reported in the last six months. Axon Enterprise Stock Performance
Axon Enterprise Stock Up 9.8%
AXON opened at $560.61 on Wednesday. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The firm has a market cap of $45.19 billion, a P/E ratio of 225.14, a PEG ratio of 10.42 and a beta of 1.45. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $885.91. The business’s fifty day simple moving average is $426.15 and its 200 day simple moving average is $481.27.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.01. The firm had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.90 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm’s revenue for the quarter was up 33.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.47 EPS. As a group, equities research analysts anticipate that Axon Enterprise, Inc will post 1.63 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on AXON shares. JPMorgan Chase & Co. raised their target price on shares of Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. UBS Group reduced their price target on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a report on Thursday, May 7th. Zacks Research upgraded shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 19th. Piper Sandler reiterated an “overweight” rating and issued a $674.00 price target on shares of Axon Enterprise in a research report on Monday, June 15th. Finally, The Goldman Sachs Group set a $535.00 price objective on shares of Axon Enterprise in a research note on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $712.75.
Read Our Latest Analysis on AXON
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
See Also
- Five stocks we like better than Axon Enterprise
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
